FindTrial
Sign In

Comparative evaluation of hemostasis achieved by different hemostatic agents for vital pulp therapy- Randomized Controlled Trial

Comparative evaluation of the effect of new hemostatic agents in vital pulp therapy- Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/079952
Enrollment
50
Registered
2025-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

Intervention1: 2.5% Sodium Hypochlorite: 2.5% Sodium Hypochlorite will be used as a haemostatic agent in vital pulp therapy procedure and time required for hemostasis will be noted Control Interventio

Sponsors

Dr Aakash Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from symptomatic irreversible pulpitis 2. patient undergoing vital pulp therapy

Exclusion criteria

Exclusion criteria: 1. Patients with acute and chronic apical abscess 2. Patients with dental trauma 3. Patients with bone or root resorption

Design outcomes

Primary

MeasureTime frame
Evaluation of efficacy of different haemostatic agents on vital pulp therapy procedure capped with biodentineTimepoint: 1 year—

Secondary

MeasureTime frame
effect of different haemostatic agent in achieving haemostasis in terms of durationTimepoint: 10 minutes—

Countries

India

Contacts

Public ContactDr Aakash Gupta

All India Institute of Medical Sciences Bathinda

guptaaakash95@gmail.com09877939523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026